Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study
Bacillus Calmette–Guerin (BCG), the only available vaccine for tuberculosis (TB), has been applied for decades. The Indonesian government recently introduced a national TB disease control programme that includes several action plans, notably enhanced vaccination coverage, which can be strengthened t...
Main Authors: | Afifah Machlaurin, Franklin Christiaan Karel Dolk, Didik Setiawan, Tjipke Sytse van der Werf, Maarten J. Postma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/4/707 |
Similar Items
-
Fighting Tuberculosis: In Search of a BCG Replacement
by: Nonna I. Nadolinskaia, et al.
Published: (2022-12-01) -
BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01) -
The role of BCG in prevention of tuberculosis and the strategies to improve its immunogenicity
by: Jolanta Mazurek
Published: (2018-03-01) -
After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
by: Mario Alberto Flores-Valdez
Published: (2021-12-01) -
Frequency of absent BCG Scar in Babies Vaccinated with BCG
by: Aqeela Sami, et al.
Published: (2023-07-01)